date/time interval
- February 1, 2023 - January 31, 2028
HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R01 CA269954-01A1
Affiliation
contributor
- Elemento, Olivier Principal Investigator (Subaward) 2023 - 2028